71 results
425
EX-10.2
HEPA
Hepion Pharmaceuticals, Inc.
22 Jul 24
Business combination disclosure
8:33am
of the ordinary shares or otherwise, the selling shareholders may enter into hedging transactions with broker-dealers, which may in turn engage in short … sales of the ordinary shares in the course of hedging in positions they assume. The selling shareholders may also sell ordinary shares short
425
EX-2.1
HEPA
Hepion Pharmaceuticals, Inc.
22 Jul 24
Business combination disclosure
8:33am
rate or foreign currency hedging;
(b) Each Contract that relates to the acquisition or disposition of any Equity Securities in, or assets or properties
8-K
EX-2.1
HEPA
Hepion Pharmaceuticals, Inc.
22 Jul 24
Entry into a Material Definitive Agreement
8:28am
rate or foreign currency hedging;
(b) Each Contract that relates to the acquisition or disposition of any Equity Securities in, or assets or properties
8-K
EX-10.2
HEPA
Hepion Pharmaceuticals, Inc.
22 Jul 24
Entry into a Material Definitive Agreement
8:28am
of the ordinary shares or otherwise, the selling shareholders may enter into hedging transactions with broker-dealers, which may in turn engage in short … sales of the ordinary shares in the course of hedging in positions they assume. The selling shareholders may also sell ordinary shares short
424B3
3z043069 7csem
15 Jul 24
Prospectus supplement
5:17pm
8-K
EX-10.1
xdt2kot0svk 4w2x3yj
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
tulopdhzuly72iia49
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
EX-10.1
306rrf4 cdiw
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-10.2
i3s0j qv03ye
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm